PROFMEDCENTR - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 116,690 | 134,503 | 119,623 | 125,204 | 117,025 | 131,299 | 114,747 | 137,552 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 5,055 | -818 | 12,085 | -7,277 | -26,927 | -87,929 | -89,187 | -39,996 |
| Equity | -4,729 | -5,547 | 6,538 | -739 | -27,666 | -115,595 | -204,782 | -191,453 |
| Liabilities | 61,145 | 54,654 | 49,793 | 170,323 | 314,742 | 529,425 | 559,029 | 485,107 |
| Non-current assets | 952 | 314 | 129 | 1,559 | 132,678 | 341,869 | 296,023 | 252,693 |
| Current assets | 55,425 | 48,746 | 56,198 | 168,018 | 155,236 | 72,305 | 58,286 | 40,981 |
| Total assets | 56,377 | 49,060 | 56,327 | 169,577 | 287,914 | 414,174 | 354,309 | 293,674 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 11,083 | 28,746 | 30,685 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +0.2% | +15.3% | -11.1% | +4.7% | -6.5% | +12.2% | -12.6% | +19.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 9.0% | -1.7% | 21.5% | -4.3% | -9.4% | -21.2% | -25.2% | -13.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | 184.8% | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 4.3% | -0.6% | 10.1% | -5.8% | -23.0% | -67.0% | -77.7% | -29.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 7.6 | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 31,117 | 35,088 | 39,874 | 50,082 | 43,884 | 43,766 | 44,419 | 71,765 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
PROFMEDCENTR - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-17 | 2026-05-26 | 3.03 |
| 2026-05-03 | 2026-05-05 | 3.03 |
| 2026-04-27 | 2026-04-29 | 3.03 |
| 2026-04-26 | 2026-04-26 | 2.80 |
| 2026-04-24 | 2026-04-25 | 3.03 |
| 2026-04-20 | 2026-04-23 | 2.80 |
| 2026-03-29 | 2026-04-06 | 2.80 |
| 2026-03-17 | 2026-03-27 | 2.80 |
| 2026-02-18 | 2026-03-05 | 2.80 |
| 2026-01-22 | 2026-02-05 | 39.22 |
| 2026-01-16 | 2026-01-21 | 36.42 |
| 2025-12-16 | 2025-12-29 | 718.87 |
| 2025-07-16 | 2025-08-04 | 7.62 |
| 2025-06-17 | 2025-07-01 | 7.62 |
| 2025-05-16 | 2025-06-02 | 7.62 |
| 2025-05-04 | 2025-05-07 | 7.62 |
| 2025-04-24 | 2025-04-29 | 7.62 |
| 2025-03-03 | 2025-03-03 | 882.26 |
| 2025-02-18 | 2025-02-27 | 882.26 |
| 2025-02-10 | 2025-02-10 | 882.27 |
| 2025-01-16 | 2025-02-04 | 882.27 |
PROFMEDCENTR - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-01-30 | 2025-02-15 | 4.22 |
| 2025-01-08 | 2025-01-22 | 4.22 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
PROFMEDCENTR, UAB (code 302784835) is a Private Limited Liability Company operating in wholesale of perfume and cosmetics. In 2025, the company generated EUR 137.6K in revenue, up 19.9% year on year and 4.8% over two years. Despite the revenue increase, it remained loss-making, reporting a net loss of EUR 40.0K, although this was a significant improvement from EUR 89.2K loss in 2024 and EUR 87.9K loss in 2023. The profit margin improved to -29.1% in 2025 from -77.7% in 2024 and -67.0% in 2023, indicating a partial recovery in operating performance. Total assets declined to EUR 293.7K from EUR 354.3K in 2024 and EUR 414.2K in 2023, while liabilities fell to EUR 485.1K from EUR 559.0K and EUR 529.4K. Equity remained negative at EUR -191.5K. Asset turnover stood at 0.47x in 2025, and revenue per employee was EUR 137.6K, with profit per employee at EUR -40.0K.